Skip to main content
. 2014 Oct 27;5(18):8123–8135. doi: 10.18632/oncotarget.2347

Figure 1. Study overview.

Figure 1

Study design comprising four different independent cohorts (MCIp - Methyl-CpG immunoprecipitation, DMR – differentially methylated region, MassARRAY® (technique by Sequenome) - matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF) mass spectrometry (MS), CRT – chemoradiotherapy, RT – radiotherapy, GER – German cohort, FRA – French cohort)